Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joseph Burnett is CEO and President at Clearpoint Neuro. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 12, 2025, each linked to the official Form 4.
CEO and President
Disclosures on record
1
Companies involved
1
Clearpoint NeuroCLPT
Jun 9, 2025Sold~$282Kdisclosed Jun 12
DetailsOfficial recordJoseph Burnett reported 4 open-market purchases and 5 sales here, 2018 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Joseph Burnett bought shares on the open market in 2018, and has not bought since 2018. Sales in 3 of the 9 years since 2018.
Joseph Burnett reported 4 open-market purchases and 5 sales since 2018; purchases in 2018.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $282K1×1 trade |
| 2022 | — | $303K1×1 trade |
| 2021 | — | $806K3×3 trades |
| 2018 | $68K4×4 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Joseph Burnett reported holding 243,522 shares of Clearpoint Neuro (CLPT), worth about $2.07M at the last close of $8 (Nov 13, 2026), held through a see footnote.
Clearpoint Neuro's proxy statement reports total compensation of $2.81M for Joseph Burnett for fiscal year 2025, after $2.53M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 10, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clearpoint Neuro CLPT | 243,522 | 244K see footnote | $8 | $2.07M | Jun 9, 2025 |
Is this Joseph Burnett’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jun 9, 2025, Joseph Burnett reported holding 243,522 shares of Clearpoint Neuro (CLPT), held indirectly. At the last close of $8 on Nov 13, 2026, that is about $2.07M. This is the stake disclosed in filings, not a net worth.
Clearpoint Neuro's proxy statement reports total compensation of $2.81M for Joseph Burnett for fiscal year 2025, after $2.53M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Joseph Burnett bought shares on the open market in 2018, and has not bought since 2018. Sales in 3 of the 9 years since 2018.
In SEC filings since 2018: the latest open-market purchase is from 2018; the latest open-market sale is from 2025.
Clearpoint Neuro (CLPT), from 2018 to 2025: 4 purchases and 5 sales.
